financetom
Business
financetom
/
Business
/
NewtekOne Closes $75 Million Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NewtekOne Closes $75 Million Notes Offering
Sep 16, 2024 12:25 PM

01:17 PM EDT, 09/16/2024 (MT Newswires) -- NewtekOne ( NEWT ) said Monday it closed a public offering of $75 million in 8.625% fixed rate senior notes due 2029.

The company can redeem these notes, in whole or in part, starting Oct. 15, 2026, at a price equal to the full amount of the principal plus any interest that has not yet been paid. Interest will be paid quarterly starting Jan. 15, 2025.

The notes will be listed on the Nasdaq Global Market under the symbol "NEWTH" within thirty days. Proceeds from the offering will be used for investments, paying off existing debt, and general corporate purposes, the company said.

Shares of NewtekOne ( NEWT ) fell 1.4% in recent trading activity.

Price: 11.08, Change: -0.16, Percent Change: -1.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lilly asks US government to pause drug price negotiations, Bloomberg News reports
Lilly asks US government to pause drug price negotiations, Bloomberg News reports
Jan 13, 2025
(Reuters) -Eli Lilly ( LLY ) has asked the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing CEO David Ricks. Ricks said at the JPMorgan Healthcare Conference that the government needs to fix the Inflation Reduction Act (IRA) before the second round of talks over price cuts, the report added. The outgoing administration...
What's Going On With 22nd Century Group Shares Monday?
What's Going On With 22nd Century Group Shares Monday?
Jan 13, 2025
22nd Century Group, Inc. ( XXII ) stock is moving higher on Monday after the company announced its readiness to support the Food and Drug Administration’s (FDA) proposed standard to mandate reduced nicotine content in cigarettes. What To Know: The proposed standard aligns with the FDA’s long-standing effort to drastically reduce nicotine levels in cigarettes and is consistent with the...
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
Jan 13 (Reuters) - U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare conference on Monday. ...
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
(Reuters) -U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday. We are all in ... we are building our teams ... We are recruiting experts in obesity over the last, let's...
Copyright 2023-2025 - www.financetom.com All Rights Reserved